Close Menu

NEW YORK — Patia Biopharma has partnered with Precision Diabetes to develop and commercialize new biomarkers for diabetes, the companies said on Wednesday.

Specific terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.